Malaysia Surrogacy: Medical and Donor Requirements
Short answer and scope
Can intended parents satisfy medical or donor conditions and then arrange surrogacy in Malaysia? The official materials do not provide such a route. Malaysia’s Ministry of Health National Assisted Reproductive Technology (ART) Policy states that surrogacy is prohibited and that a surrogacy agreement is not enforceable by law even if signed. The Malaysian Medical Council (MMC) guideline, Medically Assisted Reproduction V2/2025, repeats that surrogacy is prohibited under the National ART Policy.
This article covers screening, gametes, embryos, consent and clinic standards. A clinic’s willingness to discuss a procedure, a negative test, a genetic link or a signed agreement does not remove the policy prohibition. Pause any proposed arrangement and obtain current Malaysian legal advice before payment, signature, transfer of reproductive material or treatment.
The sources are official health policy, professional guidance and facility standards; they are not all Acts of Parliament. This guide does not claim that every breach is a standalone criminal offence and does not determine parentage, citizenship, immigration or recognition abroad.
What the official sources say—and what they are
The Ministry’s National ART Policy (MOH/P/PAK/459.21(BP)), listed on its official clinical-publications page, states that surrogacy is prohibited and agreements are unenforceable even if signed. It also addresses commercial trading in gametes/embryos and infection screening. The policy remains listed, but counsel should confirm amendments or replacement before reliance.
The MMC’s Medically Assisted Reproduction V2/2025 says MAR should generally be offered only to legally married couples. It requires written consent for the particular treatment and pre-procedure screening, and says gamete/embryo donation for fertilisation is not permissible under the National ART Policy. Its consent-section footnote refers narrowly to unmarried individuals needing fertility preservation, not a general exception for treatment intended to achieve conception. These are professional expectations for registered practitioners.
MMC says its guidelines must be observed by registered practitioners and non-compliance may result in discipline under section 29 of the Medical Act 1971. This is a possible professional consequence for doctors; it does not itself establish a standalone criminal offence by intended parents, a surrogate or an agency. Malaysian counsel must assess each actor’s position.
The Ministry’s October 2012 ART facility standards set minimum laboratory/facility requirements, including quality, handling and traceability. They do not create a surrogacy exception. Policy, professional guidance, technical standards and legislation are distinct.
Donor gametes, embryos and commercial activity
The MMC guideline says egg, sperm and embryo donation for fertilisation is not permissible and is prohibited in accordance with the National ART Policy. The policy separately prohibits commercial trading in gametes or embryos, including advertisements. The MMC guideline also lists commercial trading in reproductive tissues, gametes and embryos among prohibited or unacceptable practices. Do not assume that using a donor rather than an intended parent’s own gametes, or calling a payment a service fee, makes a plan acceptable.
The MMC guideline also lists use of fetal gametes for fertilisation and use of gametes or embryos harvested from cadavers in ART programmes among prohibited or unacceptable practices.
Malaysian rules provide no donor-gamete exception for a surrogacy programme and no universal donor-eligibility list. The materials also do not establish a verified nationwide schedule for donor compensation or expenses, donor-age limits, genetic-testing panels, or permitted donor cycles; do not infer such rules from clinic advertising or another country's law. Do not assume a donor route is permitted merely because a clinic offers it.
If a clinic proposes donor material, request the current Malaysian policy provision and written explanation of donor eligibility, consent and traceability; have Malaysian counsel check any asserted exception.
Medical screening for transmissible diseases
The National ART Policy says all persons undergoing ART should be screened for transmissible diseases before procedures. It gives HIV, hepatitis B, hepatitis C and syphilis as examples. The MMC guideline likewise says people undergoing medically assisted reproduction should be adequately tested for transmissible diseases before treatment. This is a pre-procedure screening expectation for ART, not a medical clearance certificate for surrogacy.
The cited policy does not prescribe a complete laboratory panel, result-validity period, repeat-testing schedule for every procedure, or a single threshold that guarantees acceptance. The treating clinician should set out tests and timing based on the treatment and current clinical guidance; this is not permission to proceed with surrogacy.
Before sharing medical records or samples with an agency, confirm the recipient, purpose, handling arrangements and privacy safeguards.
Other clinical tests and donor eligibility
Fertility care may also involve assessment of reproductive history, medical conditions, semen parameters, ovarian reserve, ultrasound findings or other tests relevant to the proposed treatment. These are clinical matters, not a single donor-eligibility list set by law. Ask the clinician why each test is needed and how its result affects care.
Do not assume nationwide age, BMI, genetic-panel, family-history or donor-acceptance rules unless a current Malaysian source supports them. Clinics may set extra operational criteria, but should label them clinic policy, not universal law. A test’s availability does not prove its results can lawfully be used for donor or embryo selection.
The National ART Policy also sets embryo-transfer limits for ordinary ART: for patients under 40, no more than two embryos; for patients aged 40 or above, up to three cleavage-stage embryos or two blastocysts may be transferred with agreement of all parties. Success rates and the risk of multiple pregnancy should be explained and documented as part of informed consent. These clinical limits do not create an exception for surrogacy.
The MMC guideline says embryo sex should not be selected for social or personal reasons. It describes a narrow exception where a particular sex predisposes to a serious genetic condition, giving haemophilia, Duchenne muscular dystrophy and fragile X syndrome as examples. This is not a general permission to select a preferred sex or desired characteristics.
Written consent, storage and traceability
The MMC guideline says no medically assisted reproduction treatment should be provided to a couple without written consent to that particular treatment. The treatment must be explained, including success rates and complications. Written consent is also required for treatment, storage, disposal and use of genetic material for research or training; disposal of gametes or embryos must be documented.
The guideline says the parties must address what happens to stored embryos or a deceased person’s gametes if the couple separates, divorces or one partner dies. It states that stored embryos or deceased gametes are not to be used for conception by the other partner or, where relevant, next of kin in those circumstances. Ask the clinic to explain this provision and how its consent forms and storage terms implement current policy.
Centres should keep accurate records and labels, maintain appropriate storage and handling standards, and make each sample traceable from collection. Transfers within or outside Malaysia must comply with the National ART Policy. These safeguards support ordinary ART quality and accountability; they do not legalise donor gametes or surrogacy.
Clinic and laboratory standards
The Ministry’s 2012 facility standards cover clinical and laboratory personnel, premises and equipment, preparation before procedures, collection and handling of gametes, quality assurance, storage, transfer, disposal and reporting. They state that the clinical director must be a registered medical practitioner under the Medical Act 1971, hold a valid practising certificate, have postgraduate qualifications in obstetrics and gynaecology, and be registered as a reproductive-medicine subspecialist on the National Specialist Register.
Before lawful fertility treatment, verify the responsible clinician’s registration and practising certificate, who directs the laboratory, how samples are labelled and tracked, and how storage or transfer is recorded. Request consent forms and the infection-testing protocol; ads or agency referrals do not prove authorisation.
These technical standards govern ART quality and safe operation; they do not override the policy’s surrogacy and donor restrictions.
Quick decision matrix
The matrix below separates the practical answer from the next verification step. It is a decision aid, not a substitute for checking the current Malaysian instrument and the exact facts of a proposed procedure.
| Question | Legal position | Practical next step |
|---|---|---|
| Surrogacy | Prohibited by National ART Policy; the policy says agreements are not enforceable. | Pause the plan and obtain current Malaysian legal advice. |
| Donor gametes or embryos | Donation for fertilisation is not permissible under the policy and MMC guideline; MMC also lists fetal gametes and cadaver-derived gametes/embryos as prohibited or unacceptable. | Do not assume any donor route is an exception. |
| Commercial sale or advertising | Commercial trading in gametes or embryos, including advertisements, is prohibited by policy. | Do not pay; ask for the current written legal basis. |
| Infection screening | All ART patients should be screened before procedures; examples include HIV, hepatitis B/C and syphilis. | Ask the clinician for the exact tests, timing and repeat-testing rules. |
| Consent and records | Written treatment-specific consent and documented handling/storage/disposal are required by the MMC guideline. | Obtain the forms and storage/transfer terms before treatment. |
| Who can receive ART? | MMC guidance says MAR should generally be offered only to legally married couples; a footnote narrowly refers to unmarried individuals needing fertility preservation. | Ask whether that specific fertility-preservation context applies; do not assume a general unmarried-treatment exception. |
| Embryo-transfer limits | Under 40: maximum two embryos. Age 40 or above: up to three cleavage-stage embryos or two blastocysts, with agreement of all parties; informed consent must address success rates and multiple-pregnancy risk. | Ask the clinician to apply the correct age/stage rule and document informed consent. |
| Cross-border transfer of material | The National ART Policy says special permission from the Ministry of Health is required to transfer gametes, reproductive tissues or embryos across Malaysia’s border. | Confirm the current process and obtain the required permission before shipment. |
Practical sequence before contacting a clinic or agency
First, define the treatment precisely: ordinary fertility treatment using the patient’s own gametes, fertility preservation, donor gametes, embryo donation, or pregnancy carried by another woman. “IVF” names a technique; it does not answer whether the whole arrangement is permitted.
If another woman would carry a pregnancy for intended parents, stop before payment, contract, embryo creation or transfer. The policy says surrogacy is prohibited and its agreements unenforceable. Obtain independent Malaysian advice on current rules and party-specific consequences; do not rely on an agency’s promise that a contract, genetic link or foreign document solves the issue.
For lawful ART that does not involve surrogacy or prohibited donor material, request a written clinical plan identifying the procedure, required tests, persons to be tested, consent forms, storage and disposal choices, responsible doctor and sample-tracking process. Ask the clinic to distinguish national-policy or professional-guidance requirements from its own protocol.
The policy requires special Ministry of Health permission to transfer gametes, reproductive tissues or embryos across Malaysia’s border. Before shipment, confirm the current process with the clinic and Malaysian counsel and obtain that permission. Verify origin, authorised handlers, identity checks, tracking and what happens if delivery is delayed or refused; an overseas bank or donor does not change the policy position.
Keep the policy version, clinic’s written response, professional registration details, test results, signed consent forms, storage terms and transfer records. Do not pay for a donor or surrogacy package until its content and legal basis have been independently checked.
Limits of the evidence and conclusion
The official sources support the policy position described here but do not resolve every legal question. The National ART Policy PDF is linked from the Ministry’s official publications page; relevant clauses were visually checked in the rendered PDF, although automated full-text extraction remains incomplete. The 2012 facility standards were available as a full-text PDF.
Counsel should also assess the legal effect of the unenforceability statement, possible administrative or professional sanctions, and any state-specific or religious-law issues. This guide does not say surrogacy automatically constitutes a crime or determine parentage or nationality.
Medical screening and clinic standards do not create a route around the surrogacy prohibition. The National ART Policy prohibits surrogacy, says its agreements are unenforceable, prohibits commercial trading in gametes/embryos, requires infection screening, sets embryo-transfer limits and requires special Ministry of Health permission for cross-border reproductive-material transfers; the transfer-permission and embryo-transfer provisions should be checked against the current version. MMC guidance prohibits gamete/embryo donation for fertilisation and also identifies fetal gametes and cadaver-derived material as prohibited or unacceptable; it generally limits MAR to married couples subject to a narrow fertility-preservation footnote and requires written consent and records. Obtain written clinic responses and independent Malaysian legal advice before payment, signature, treatment or transfer.
Sources
- [S1] National Assisted Reproductive Technology (ART) Policy (MOH/P/PAK/459.21(BP)) — Official source; check current amendments before reliance.
- [S2] Guideline of the Malaysian Medical Council: Medically Assisted Reproduction V2/2025 — Official source; check current amendments before reliance.
- [S3] Standards for Assisted Reproductive Technology Facility — Embryology Laboratory and Operation Theatre (October 2012) — Official source; check current amendments before reliance.
- [S4] Ministry of Health Malaysia — Official clinical publications listing: Obstetrics and Gynaecology / Paediatrics — Official source; check current amendments before reliance.
- [S5] Malaysian Medical Council — Laws & Regulations — Official source; says MMC guidelines must be observed by registered practitioners and non-compliance may result in disciplinary action under section 29 of the Medical Act 1971. Verify current law before reliance.
